Toll-like receptor 9 (TLR9) is a cellular DNA receptor of the innate immune system. DNA
recognition via TLR9 results in an inflammatory reaction, which eventually also activates a …

Objective: To review presentation, diagnosis, treatment and prognosis of male breast
cancer. Method: A systematic review of the English language literature between 1990 and …

Tamoxifen is known as a standard therapeutic treatment for estrogen receptor-positive
breast cancer, which down-regulates breast cancer mortality by 31% approximately …

Breast carcinomas in both genders share pathological features, although differences in
incidence, prognosis and survival are reported. Expression of 33 genes was investigated in …

El cáncer de mama en hombres es una entidad rara y constituye menos del 1% de todos los
tumores de mama. En Colombia la incidencia estimada anual es de 0.1 casos por 100.000 …

El cáncer de mama en hombres es una enfermedad poco frecuente, en Colombia la
incidencia estimada anual es de 1 caso por cada 1.000. 000 de habitantes, lo cual es …

Cancer in general, and specifically gynaecological neoplasms, represents a major public
health issue worldwide. Based on the effect of sex hormones on breast tumorigenesis and …

Background Male breast cancer is a rare and less known disease. Therapeutic modalities
affect survival. In Burkina Faso, male breast cancers are diagnosed in everyday practice, but …

Background: One of the most important reasons for the high mortality rates of cancer is the
low level of awareness, which can lead to a late diagnosis and treatments starting too late …

Background: Male breast cancer is a rare neoplasm, and its treatments are based on those
of female breastcancer. This study aimed to analyze 20 years of male breast cancer clinical …